Literature DB >> 2821567

Platelet 3H-rauwolscine binding in patients with panic attacks.

T R Norman1, N M Kimber, F K Judd, G D Burrows, I M McIntyre.   

Abstract

Platelet alpha 2 binding was measured in 14 patients with panic attacks and 21 controls using the antagonist 3H-rauwolscine as radioligand. The mean (+/- SD) Bmax values of patients (116 +/- 45 fmoles/mg protein) and controls (106 +/- 32 fmoles/mg protein) was not significantly different (p greater than 0.05, Mann-Whitney U test). There was a nonsignificant trend for the Kd of patients (1.25 +/- 0.67 nM) to be higher than that of controls (0.96 +/- 0.32 nM). The results do not support an adrenergic abnormality in panic patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2821567     DOI: 10.1016/0165-1781(87)90049-7

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  3 in total

1.  Platelet alpha-2-receptor binding and adenylate cyclase activity in panic disorder.

Authors:  D S Charney; R B Innis; R S Duman; S W Woods; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Psychophysiological and biochemical changes in patients with panic attacks in a defined situational arousal.

Authors:  S Braune; M Albus; M Fröhler; T Höhn; G Scheibe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

3.  Comparison of 3H-para-aminoclonidine binding to different platelet preparations.

Authors:  J E Piletz; A Halaris
Journal:  J Neural Transm Gen Sect       Date:  1990
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.